The mutant protein then interferes with the remaining normal DNMT3A to form active tetramers that reduces the enzyme activity and hypomethylation at specific cytosine‐guanine dinucleotides in early AML cells.34 This evidence concerns the gene DNMT3A and acute myeloid leukemia.